OBSOLETE: Syndromic ichthyosis associated with ocular features Advocacy Hub | UniteRare

At a Glance

Live from database

No FDA or trial events recorded yet for OBSOLETE: Syndromic ichthyosis associated with ocular features.

1 program

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Patient Assistance Programs1

Megace

Bristol-Myers Squibb Pharmaceutical Research Institute

OpenContact for detailsApply ↗

1 FDA-approved

Megace

(Megestrol acetate)Orphan drugstandard

Bristol-Myers Squibb Pharmaceutical Research Institute

No active clinical trials currently recruiting for OBSOLETE: Syndromic ichthyosis associated with ocular features.
Search all trials →

No recent news articles indexed yet for OBSOLETE: Syndromic ichthyosis associated with ocular features.
Search PubMed for OBSOLETE: Syndromic ichthyosis associated with ocular features →

No specialists currently listed for OBSOLETE: Syndromic ichthyosis associated with ocular features.

View Disease Page

Full profile, treatments, community

Search Clinical Trials

Find recruiting studies now

Find Specialists

Ranked by expertise & trials

Financial Assistance

Copay cards, PAPs, grants